Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 11786108)

Published in Kidney Int on January 01, 2002

Authors

Will McKane1, Shahid M Chandna, James E Tattersall, Roger N Greenwood, Ken Farrington

Author Affiliations

1: Lister Renal Unit Stevenage, and Renal Unit, Northern General Hospital, Sheffield, England, United Kingdom.

Articles citing this

Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol (2010) 1.52

Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial (2013) 1.16

Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol (2010) 1.02

Predictors of residual renal function decline in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int (2014) 0.95

Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients. J Am Soc Nephrol (2016) 0.92

Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study. Nephrol Dial Transplant (2008) 0.90

Residual renal function and nutrition in young patients on chronic hemodialysis. Pediatr Nephrol (2009) 0.81

Incremental peritoneal dialysis favourably compares with hemodialysis as a bridge to renal transplantation. Int J Nephrol (2011) 0.80

The importance of residual renal function in chronic dialysed patients. J Med Life (2010) 0.78

Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making. NDT Plus (2011) 0.76

Residual renal function in children treated with chronic peritoneal dialysis. ScientificWorldJournal (2013) 0.75

Advances in Understanding and Management of Residual Renal Function in Patients with Chronic Kidney Disease. Kidney Dis (Basel) (2016) 0.75

Rationale and design of BISTRO: a randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients. BMC Nephrol (2017) 0.75

Introduction to the Critical Balance - Residual Kidney Function and Incremental Transition to Dialysis. Semin Dial (2017) 0.75

Different treatment options in peritoneal dialysis. NDT Plus (2008) 0.75

Effect of N-acetylcysteine on residual renal function in chronic haemodialysis patients treated with high-flux synthetic dialysis membranes: a pilot study. ISRN Nephrol (2012) 0.75

Strategies for the preservation of residual renal function in pediatric dialysis patients. Pediatr Nephrol (2013) 0.75

Articles by these authors

Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int (2002) 3.79

Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract (2003) 2.96

Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant (2010) 2.67

Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int (2008) 2.34

An association between depressive symptoms and survival in incident dialysis patients. Nephrol Dial Transplant (2010) 2.23

Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int (2004) 2.15

Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant (2010) 2.00

Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant (2009) 1.99

The ESHOL study: hemodiafiltration improves survival-but how? Kidney Int (2013) 1.98

Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis. Clin J Am Soc Nephrol (2012) 1.98

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant (2009) 1.58

Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol (2008) 1.52

Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol (2010) 1.51

Measuring the quality of end of life management in patients with advanced kidney disease: results from the pan-Thames renal audit group. Nephrol Dial Transplant (2011) 1.49

International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol (2006) 1.49

Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration. Hemodial Int (2011) 1.45

The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant (2008) 1.39

The haemodynamic response to submaximal exercise during isovolaemic haemodialysis. Nephrol Dial Transplant (2004) 1.38

Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Qual Life Res (2007) 1.35

Simulation model of renal replacement therapy: predicting future demand in England. Nephrol Dial Transplant (2004) 1.34

Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol (2009) 1.27

Emerging importance of residual renal function in end-stage renal failure. Semin Dial (2011) 1.19

Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2012) 1.15

Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract (2008) 1.12

Depression on dialysis. Nephron Clin Pract (2008) 1.09

Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int (2002) 1.07

Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif (2007) 1.01

Automated monitoring of hemodialysis adequacy by dialysis machines: potential benefits to patients and cost savings. Kidney Int (2010) 0.98

Erythropoietic stress and anemia in diabetes mellitus. Nat Rev Endocrinol (2009) 0.96

Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidity. Nephrol Dial Transplant (2004) 0.96

Natriuretic peptides and the dialysis patient. Semin Dial (2005) 0.96

Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial (2004) 0.94

Dialysis dose in acute kidney injury and chronic dialysis. Lancet (2010) 0.94

Illness perceptions predict survival in haemodialysis patients. Am J Nephrol (2011) 0.93

Analytical quality goals for parathyroid hormone based on biological variation. Clin Chem Lab Med (2008) 0.93

Illness representations are associated with fluid nonadherence among hemodialysis patients. J Psychosom Res (2009) 0.91

Serial determinations of absolute plasma volume with indocyanine green during hemodialysis. J Am Soc Nephrol (2003) 0.91

Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother (2003) 0.91

Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants. Semin Dial (2013) 0.91

Screening for depression while patients dialyse: an evaluation. Nephrol Dial Transplant (2008) 0.90

Factors affecting long-term survival of tunnelled haemodialysis catheters--a prospective audit of 812 tunnelled catheters. Nephrol Dial Transplant (2007) 0.90

Supportive care in advanced kidney disease: patient attitudes and expectations. J Ren Care (2014) 0.90

Analytical quality goals for 25-vitamin D based on biological variation. J Clin Lab Anal (2011) 0.89

The factor structure of the Revised Illness Perception Questionnaire (IPQ-R) in end-stage renal disease patients. Psychol Health Med (2012) 0.89

Summary of the 5th edition of the Renal Association Clinical Practice Guidelines (2009-2012). Nephron Clin Pract (2011) 0.88

UK Renal Registry 12th Annual Report (December 2009): chapter 10: biochemistry profile of patients receiving dialysis in the UK in 2008: national and centre-specific analyses. Nephron Clin Pract (2010) 0.88

Distinct depression symptom trajectories over the first year of dialysis: associations with illness perceptions. Ann Behav Med (2013) 0.88

Spinal cord infarction following central-line insertion. Ren Fail (2003) 0.88

Communication as care at end of life: an emerging issue from an exploratory action research study of renal end-of-life care for ethnic minorities in the UK. J Ren Care (2014) 0.87

The relationship between systemic and whole-body hematocrit is not constant during ultrafiltration on hemodialysis. J Am Soc Nephrol (2004) 0.86

Depression in end-stage renal disease: current advances and research. Semin Dial (2009) 0.86

Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease. Eur Heart J (2012) 0.86

A predictive algorithm for the management of anaemia in haemodialysis patients based on ESA pharmacodynamics: better results for less work. Nephrol Dial Transplant (2011) 0.86

The clinical significance of early proteinuria after renal transplantation. Transplantation (2010) 0.85

How robust is the 'surprise question' in predicting short-term mortality risk in haemodialysis patients? Nephron Clin Pract (2013) 0.84

Are low erythropoietin and 1,25-dihydroxyvitamin D levels indicative of tubulo-interstitial dysfunction in diabetes without persistent microalbuminuria? Diabetes Res Clin Pract (2009) 0.84

Selected lessons learned from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Contrib Nephrol (2005) 0.84

Energy metabolism, body composition, and urea generation rate in hemodialysis patients. Hemodial Int (2013) 0.83

Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Hemodial Int (2006) 0.83

Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. Diabetes Res Clin Pract (2012) 0.83

A comparison of methods for determining urea distribution volume for routine use in on-line monitoring of haemodialysis adequacy. Nephrol Dial Transplant (2008) 0.83

Linear decay of relative blood volume during ultrafiltration predicts hemodynamic instability. Am J Kidney Dis (2002) 0.83

A self-report comorbidity questionnaire for haemodialysis patients. BMC Nephrol (2014) 0.82

Exploring the views of patients not on the transplant waiting list: a qualitative study. J Ren Care (2013) 0.82

Lack of awareness of kidney complications despite familiarity with diabetes: a multi-ethnic qualitative study. J Ren Care (2011) 0.82

Endotoxemia in end-stage kidney disease. Semin Dial (2014) 0.82

Waldenstrom's macroglobulinemia presenting as Goodpasture's syndrome. Ren Fail (2004) 0.81

Human uraemic serum displays calcific potential in vitro that increases with advancing chronic kidney disease. Clin Sci (Lond) (2013) 0.81

A confirmatory factor analysis of the Beck Depression Inventory-II in end-stage renal disease patients. J Psychosom Res (2011) 0.81

A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency. Nephrol Dial Transplant (2005) 0.81

UK National Survey of Practice Patterns of Fluid Volume Management in Haemodialysis Patients: A Need for Evidence. Blood Purif (2016) 0.80

Illness representations and concurrent depression symptoms in haemodialysis patients. J Health Psychol (2011) 0.80

Choosing not to take phosphate binders: the role of dialysis patients' medication beliefs. Nephron Clin Pract (2011) 0.80

Predictors of recurrent hyperparathyroidism after total parathyroidectomy in chronic renal failure. Nephron Clin Pract (2003) 0.79

Infective spondylodiscitis in patients on high-flux hemodialysis and on-line hemodiafiltration. Hemodial Int (2008) 0.79

Identifying depression in South asian patients with end-stage renal disease: considerations for practice. Nephron Extra (2011) 0.79

Dialysis amyloid: the bottom line. Nephrol Dial Transplant (2005) 0.78

Determinants of left ventricular hypertrophy and its progression in high-flux haemodialysis. Blood Purif (2003) 0.78

Effect of ultrafiltration on thermal variables, skin temperature, skin blood flow, and energy expenditure during ultrapure hemodialysis. J Am Soc Nephrol (2005) 0.78

A multi-centre qualitative study exploring the experiences of UK South Asian and white diabetic patients referred for renal care. BMC Nephrol (2012) 0.78

Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase. Nephrol Dial Transplant (2005) 0.78

Evidence that self-affirmation improves phosphate control in hemodialysis patients: a pilot cluster randomized controlled trial. Ann Behav Med (2014) 0.78

Dalteparin dosing in high-flux haemodialysis and haemodiafiltration. Nephron Clin Pract (2013) 0.77

Haemodynamic effects of food intake during haemodialysis. Blood Purif (2008) 0.77

UK Renal Registry 13th Annual Report (December 2010): Chapter 11: blood pressure profile of prevalent patients receiving renal replacement therapy in England, Wales and Northern Ireland in 2009: national and centre-specific analyses. Nephron Clin Pract (2011) 0.77

Harnessing the microcirculation to increase dialysis efficiency. Nephron (2002) 0.77

Sleep apnoea in end-stage renal disease: a short review of mechanisms and potential benefit from its treatment. Nephrol Dial Transplant (2006) 0.77

Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus. Acta Diabetol (2009) 0.76

Acute renal failure following intravesical bacille Calmette-Guérin chemotherapy for superficial carcinoma of the bladder. Nephrol Dial Transplant (2005) 0.76

Patients' and carers' experiences of interacting with home haemodialysis technology: implications for quality and safety. BMC Nephrol (2014) 0.76

Knowing what we do and doing what we should: quality assurance in hemodialysis. Nephron Clin Pract (2014) 0.76

Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2). Nephrol Dial Transplant (2016) 0.75